Moors & Cabot, Inc.
- SEC CIK
- 0001607239
- Latest filing
- Aug 10, 2026
KPTI holding history
Karyopharm Therapeutics Inc. in every 13F filed by Moors & Cabot, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KPTI overviewAll 13F holders of KPTIFull Q2 2026 holdings
- Shares (Q2 2023)
- 0
- Sold out in Q2 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2023 | 0 | $0 | 0.0% | −12,200−100.0% | Sold out | Holders |
| Q1 2023 | 12,200 | $47.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 12,200 | $41.5K | <0.1% | −8,950−42.3% | Reduced | Holders |
| Q3 2022 | 21,150 | $115.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 21,150 | $95.0K | <0.1% | −400−1.9% | Reduced | Holders |
| Q1 2022 | 21,550 | $159.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 21,550 | $139.0K | <0.1% | +400+1.9% | Added | Holders |
| Q3 2021 | 21,150 | $123.0K | <0.1% | +2,500+13.4% | Added | Holders |
| Q2 2021 | 18,650 | $192.0K | <0.1% | −300−1.6% | Reduced | Holders |
| Q1 2021 | 18,950 | $199.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.